Comparison 15: NK1 receptor antagonist GR205171 vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS total score · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 24 participantsVery low